LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Management of Cystoid Macular Edema After Vitrectomy for Proliferative Vitreoretinopathy.

    Busquets, Miguel A / Lutz, Calvin T / Zhao, Tailun

    Ophthalmic surgery, lasers & imaging retina

    2020  Volume 51, Issue 8, Page(s) 436–443

    Abstract: Background and objective: To assess therapies for cystoid macular edema (CME) following pars plana vitrectomy for proliferative vitreoretinopathy (PVR).: Patients and methods: Retrospective analysis of 42 eyes developing CME after PVR surgery. ... ...

    Abstract Background and objective: To assess therapies for cystoid macular edema (CME) following pars plana vitrectomy for proliferative vitreoretinopathy (PVR).
    Patients and methods: Retrospective analysis of 42 eyes developing CME after PVR surgery. Treatments included topical therapy, sub-Tenon's triamcinolone acetonide (STTA), intravitreal bevacizumab and combinations thereof. Best-corrected visual acuity (BCVA) as well as central subfield thickness (CST) were tracked.
    Results: Mean Snellen BCVA improved from 20/598 to 20/297 (logMAR change -0.21; confidence interval [CI], -0.39 to -0.03; P = .03). Mean CST improved from 448 µm to 260 µm (CI, -248.70 to -126.06; P < 0.01). There was no difference in efficacy between treatment subgroups (analysis of variance, P = 0.16, 0.43), but STTA yielded statistically significant improvement in both categories (CI, -0.79 to -0.11; P = 0.01; and CI, -333.74 to 166.51; P < .01).
    Conclusions: Treatment of CME following PVR surgery is possible with a variety of different options. STTA appears to yield anatomical and visual improvement. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:436-443.].
    MeSH term(s) Aged ; Angiogenesis Inhibitors/administration & dosage ; Bevacizumab/administration & dosage ; Disease Management ; Female ; Follow-Up Studies ; Glucocorticoids/administration & dosage ; Humans ; Intravitreal Injections ; Macular Edema/diagnosis ; Macular Edema/etiology ; Macular Edema/therapy ; Male ; Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors ; Retrospective Studies ; Tomography, Optical Coherence ; Treatment Outcome ; Triamcinolone Acetonide/administration & dosage ; Visual Acuity ; Vitrectomy/adverse effects ; Vitreoretinopathy, Proliferative/surgery
    Chemical Substances Angiogenesis Inhibitors ; Glucocorticoids ; Bevacizumab (2S9ZZM9Q9V) ; Receptors, Vascular Endothelial Growth Factor (EC 2.7.10.1) ; Triamcinolone Acetonide (F446C597KA)
    Language English
    Publishing date 2020-08-18
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701167-7
    ISSN 2325-8179 ; 2325-8160
    ISSN (online) 2325-8179
    ISSN 2325-8160
    DOI 10.3928/23258160-20200804-03
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: COVID-19 contagious health care personnel 5-day early return-to-work program.

    Wagester, Suzanne / Smith, Patricia / Lutz, Calvin T / Chung, Ashley / Tanis, Mark D / O'Hare, Colleen / Mallon, Abbie / Minnier, Tami E / Silvaggio, Teresa / Ruscetti, Amy / Chrisman, Maddie / Zapf, Rachel L / Kip, Paula L / Snyder, Graham M

    American journal of infection control

    2022  Volume 51, Issue 7, Page(s) 746–750

    Abstract: Background: COVID-19 contagious health care personnel (HCP) who are self-isolating for a 10-day period increases burden to workforce shortages. Implementation of a 5-day early return-to-work (RTW) program may reduce self-isolation periods, without ... ...

    Abstract Background: COVID-19 contagious health care personnel (HCP) who are self-isolating for a 10-day period increases burden to workforce shortages. Implementation of a 5-day early return-to-work (RTW) program may reduce self-isolation periods, without increasing transmission risk, during the COVID-19 pandemic.
    Design and methods: This observational cohort quality improvement study included newly diagnosed COVID-19 HCP at a multifacility health care system. The program allowed HCP to return to work 6 days after date of a positive test result if they were not immunocompromised, had mild and improving symptoms, and self-reported a SARS-CoV-2 antigen negative test on day 5.
    Results: Between January 4 and April 3, 2022, 1,023 HCP self-enrolled and 344 (33.6%) self-reported negative test results. Among these, 161 (46.8%) self-reported negative test results on day 5 and were eligible for early RTW on day 6. A total of 714 days were saved from missed work in self-isolation. The number of tests purchased, dispensed, and reported per day of HCP time saved was 4.4. No transmission events were observed originating from HCP who participated in early RTW.
    Conclusion: Implementing a 5-day early RTW program that includes HCP self-reporting SARS-CoV-2 antigen test results can increase staffing availability, while maintaining a low risk of SARS-CoV-2 transmission.
    MeSH term(s) Humans ; COVID-19 ; SARS-CoV-2 ; Return to Work ; Pandemics/prevention & control ; COVID-19 Testing ; Health Personnel
    Language English
    Publishing date 2022-11-19
    Publishing country United States
    Document type Observational Study ; Journal Article
    ZDB-ID 392362-9
    ISSN 1527-3296 ; 0196-6553
    ISSN (online) 1527-3296
    ISSN 0196-6553
    DOI 10.1016/j.ajic.2022.11.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Healthcare personnel early return-to-work program after higher-risk SARS-CoV-2 exposure: A learning health system quality improvement project.

    Ruscetti, Amy / Chrisman, Maddie / Wagester, Suzanne / Smith, Patricia / O'Hare, Colleen / Mallon, Abbie / Chung, Ashley / Lutz, Calvin T / Minnier, Tamra E / Zapf, Rachel L / Kip, Paula L / Snyder, Graham M

    American journal of infection control

    2022  Volume 50, Issue 5, Page(s) 542–547

    Abstract: Background: Incidence of health care personnel (HCP) with a higher-risk SARS-CoV-2 exposure and subsequent 14-day quarantine period adds substantial burden on the workforce. Implementation of an early return-to-work (RTW) program may reduce quarantine ... ...

    Abstract Background: Incidence of health care personnel (HCP) with a higher-risk SARS-CoV-2 exposure and subsequent 14-day quarantine period adds substantial burden on the workforce. Implementation of an early return-to-work (RTW) program may reduce quarantine periods for asymptomatic HCP and reduce workforce shortages during the COVID-19 pandemic.
    Methods: This observational quality improvement study included asymptomatic HCP of a multi-facility health care system with higher-risk workplace or non-household community SARS-CoV-2 exposure ≤4 days. The program allowed HCP to return to work 8 days after exposure if they remained asymptomatic through day 7 with day 5-7 SARS-CoV-2 nucleic acid amplification test result negative.
    Results: Between January 4 and June 25, 2021, 384 HCP were enrolled, 333 (86.7%) remained asymptomatic and of these, 323 (97%) tested negative and were early RTW eligible. Mean days in quarantine was 8.16 (SD 2.40). Median day of early RTW was 8 (range 6-9, IQR 8-8). Mean days saved from missed work was 1.84 (SD 0.52). A total of 297 (92%) HCP did RTW ≤10 days from exposure and days saved from missed work was 546.48.
    Conclusions: Implementing an HCP early RTW program is a clinical approach for COVID-19 workplace safety that can increase staffing availability, while maintaining a low risk of SARS-CoV-2 transmission.
    MeSH term(s) COVID-19/prevention & control ; Delivery of Health Care ; Health Personnel ; Humans ; Learning Health System ; Pandemics ; Quality Improvement ; Return to Work ; SARS-CoV-2
    Language English
    Publishing date 2022-02-04
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 392362-9
    ISSN 1527-3296 ; 0196-6553
    ISSN (online) 1527-3296
    ISSN 0196-6553
    DOI 10.1016/j.ajic.2022.01.027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top